SPECTROM Training for Training Group
Trial Summary
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the SPECTROM Training treatment?
The research suggests that training programs for dual diagnosis (mental health and substance misuse) have been positively evaluated by participants, indicating potential effectiveness. Additionally, pilot studies of interventions for dual diagnosis treatment have shown positive results, suggesting that similar training programs like SPECTROM could be beneficial.12345
How is SPECTROM Training different from other treatments for dual diagnosis?
SPECTROM Training is unique because it focuses on training healthcare providers in dual diagnosis, which involves both mental health and substance misuse, rather than directly treating patients. This approach aims to improve the skills and confidence of healthcare providers, which can lead to better patient outcomes.13678
What is the purpose of this trial?
This is a clinical trial, with participants undergoing the 16 hour SPECTROM training, and completing 2 assessments before and after training (the Psychotropic Knowledge Questionnaire-Revised and the Management of Aggression and Violence Attitude Scale-Revised-ID).
Eligibility Criteria
This trial is for English-speaking individuals aged 18 or older who work at the 3 ARCA group homes or the UNM psychiatric center. It's designed to help them improve their understanding and management of dual diagnosis conditions.Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo the 16-hour SPECTROM training and complete assessments
Follow-up
Participants are monitored for knowledge retention and behavior management effectiveness
Treatment Details
Interventions
- SPECTROM Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of New Mexico
Lead Sponsor